# A Real-World Study of Toripalimab in Chinese Patients With Lung Cancer(THUNDER Study)

> **NCT05652712** · — · UNKNOWN · sponsor: **Qianfoshan Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** Toripalimab

## Key facts

- **NCT ID:** NCT05652712
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-06-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05652712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05652712, "A Real-World Study of Toripalimab in Chinese Patients With Lung Cancer(THUNDER Study)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05652712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*